Report
Luis Arredondo
EUR 50.00 For Business Accounts Only

ROVI: MENSAJES DEL CAPITAL MARKETS DAY (ANÁLISIS BANCO SABADELL)

De la presentación realizada hoy en su Capital Markets Day destacamos los siguientes mensajes:
 Guidance: Reiteró su guidance’23 de disminución de ingresos operativos en la banda baja de la segunda decena (es decir entre -10% y -20%; vs +0% BS(e)) que seguimos viendo conservador y pensamos que podría revisar al alza en próximos trimestres con el incremento de pedidos de vacunas a Moderna (actualmente ~4.500/5.500 M dólares).
Underlying
Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi is engaged in the sale of its own pharmaceutical products and the distribution of other products for which it holds licenses granted by other laboratories for specific periods, in accordance with the terms and conditions contained in the agreements entered into with said laboratories.

Provider
Sabadell
Sabadell

Analysts
Luis Arredondo

Other Reports on these Companies
Other Reports from Sabadell

ResearchPool Subscriptions

Get the most out of your insights

Get in touch